Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chronic kidney disease and NLRP3 inflammasome: Pathogenesis, development and targeted therapeutic strategies
Gengzhen Huang, Yaodan Zhang, Yingying Zhang, et al.
Biochemistry and Biophysics Reports (2022) Vol. 33, pp. 101417-101417
Open Access | Times Cited: 25

Showing 25 citing articles:

Obstructive nephropathy and molecular pathophysiology of renal interstitial fibrosis
Rikke Nørregaard, Henricus A. M. Mutsaers, Jørgen Frøkiær, et al.
Physiological Reviews (2023) Vol. 103, Iss. 4, pp. 2847-2892
Open Access | Times Cited: 42
The Interplay between Immune and Metabolic Pathways in Kidney Disease
Lili Qu, Baihai Jiao
Cells (2023) Vol. 12, Iss. 12, pp. 1584-1584
Open Access | Times Cited: 29
Renal macrophages and NLRP3 inflammasomes in kidney diseases and therapeutics
Mohammad Islamuddin, Xuebin Qin
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 9
Role of mitochondria in pathogenesis and therapy of renal fibrosis
Xiaodong Zhao, Yunkuo Li, Jinyu Yu, et al.
Metabolism (2024) Vol. 155, pp. 155913-155913
Closed Access | Times Cited: 7
The Kidney in Obesity: Current Evidence, Perspectives and Controversies
Dimitris Kounatidis, Natalia G. Vallianou, Theodora Stratigou, et al.
Current Obesity Reports (2024) Vol. 13, Iss. 4, pp. 680-702
Closed Access | Times Cited: 7
Targeting the NLRP3 inflammasome as a novel therapeutic target for osteoarthritis
Varnita Karmakar, Mayukh Chain, Ankit Majie, et al.
Inflammopharmacology (2025)
Closed Access
Role of Peripheral NLRP3 Inflammasome in Cognitive Impairments: Insights of Non-central Factors
Min Qiao, Junjun Ni, Hong Qing, et al.
Molecular Neurobiology (2025)
Closed Access
Inflammation in glomerular diseases
Yulong Xiong, Wei Li, Songzhi Jin, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Dead-End protein expression, function, and mutation in cancer: a systematic review
H. Faraji, Farnaz Banakar, Arash Sadri, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
Repurposing Secukinumab and Dapagliflozin as Candidate Therapies to Mitigate the Renal Toxicity of Sunitinib in Rats Through Suppressing IL‐17‐Mediated Pyroptosis and Promoting Autophagy
Rania A. Elrashidy, Hoda E. Mohamad, Sara M. Abdel Aal, et al.
Journal of Biochemical and Molecular Toxicology (2025) Vol. 39, Iss. 3
Closed Access
Dual soluble epoxide hydrolase inhibitor – farnesoid X receptor agonist interventional treatment attenuates renal inflammation and fibrosis
Abdul H. Khan, Benjamin G. Nolan, Anna Stavniichuk, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 2
Oleuropein attenuates the nephrotoxic effect of sunitinib in rats: Unraveling the potential role of SIRT6/Notch-1/NLRP-3/IL-1β axis
Rania A. Elrashidy, Hoda E. Mohamed, Sara M. Abdel Aal, et al.
Archives of Biochemistry and Biophysics (2024) Vol. 755, pp. 109986-109986
Closed Access | Times Cited: 2
Cholesterol crystals in the pathogenesis of atherosclerosis
Yvonne Baumer, Jason Irei, William A. Boisvert
Nature Reviews Cardiology (2024)
Closed Access | Times Cited: 2
The intellectual base and global trends in inflammation of diabetic kidney disease: a bibliometric analysis
LuYao Shi, Chang‐Yan Li, Jian Wang, et al.
Renal Failure (2023) Vol. 45, Iss. 2
Open Access | Times Cited: 6
Association between NLRP3 rs10754558 and CARD8 rs2043211 Variants and Susceptibility to Chronic Kidney Disease
Antonella La Russa, Danilo Lofaro, Alberto Montesanto, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 4184-4184
Open Access | Times Cited: 5
Mitochondrial Impairment: A Link for Inflammatory Responses Activation in the Cardiorenal Syndrome Type 4
Isabel Amador‐Martínez, Omar Emiliano Aparicio‐Trejo, Bismarck Bernabe-Yepes, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15875-15875
Open Access | Times Cited: 5
Inflammasome pathway in kidney transplantation
Simona Granata, Daniele La Russa, Giovanni Stallone, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 5
Study on the mechanism of hirudin multi target delaying renal function decline in chronic kidney disease based on the “gut-kidney axis” theory
Chunli Long, Chenyun Zhang, Yongxiang Xie
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 10, pp. 7951-7962
Open Access | Times Cited: 1
Pyridazine Derivatives as NLRP3 Inhibitors for Treating Asthma, COPD, Parkinson’s Disease, and Alzheimer’s Disease
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 8, pp. 1047-1048
Open Access | Times Cited: 3
The Interplay Between Immune and Metabolic Pathways in Kidney Disease
Baihai Jiao, Lili Qu
(2023)
Open Access | Times Cited: 2
Biological function of miRNA-145-5p in angiotensin II induced renal inflammation
Bin Li, YUCHENG SHENG, Xiaoying Xu, et al.
Biocell (2024) Vol. 48, Iss. 4, pp. 601-611
Open Access
Aging and chronic kidney disease: epidemiology, therapy, management and the role of immunity
Yukun Tang, Jipin Jiang, Yuanyuan Zhao, et al.
Clinical Kidney Journal (2024) Vol. 17, Iss. 9
Open Access
How PPAR-alpha mediated inflammation may affect the pathophysiology of chronic kidney disease
Sepiso K. Masenga, Selam Desta, Mark D. Hatcher, et al.
Current Research in Physiology (2024) Vol. 8, pp. 100133-100133
Open Access
Prevention of New-Onset Heart Failure in Atrial Fibrillation: The Role of Pharmacological Management
Amirreza Zobdeh, D Hoyle, P. Shastri, et al.
American Journal of Cardiovascular Drugs (2024)
Closed Access
Fused Bicyclic Heteroaryl Compounds as NLRP3 Inhibitors for Treating Asthma or COPD
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 7, pp. 895-896
Open Access | Times Cited: 1
Page 1

Scroll to top